{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:53:41Z","timestamp":1793076821747,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI143910"],"award-info":[{"award-number":["R01AI143910"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.idc.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T05:33:41Z","timestamp":1601444021000},"page":"709-722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"title":["Multidrug-Resistant Bacteria in the Community"],"prefix":"10.1016","volume":"34","author":[{"given":"David","family":"van Duin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2020.08.002_bib1","article-title":"Antibiotic resistance threats in the United States","year":"2019","journal-title":"U.S. Department of Health and Human Services"},{"key":"10.1016\/j.idc.2020.08.002_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3949\/ccjm.80a.12182","article-title":"Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients","volume":"80","author":"Perez","year":"2013","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.idc.2020.08.002_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.1993.03500050076029","article-title":"The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study","volume":"269","author":"Ena","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1086\/323459","article-title":"Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998","volume":"184","author":"Morin","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2020.08.002_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2020.08.002_bib7","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMc1910648","article-title":"Extensively Drug-Resistant Shigellosis in Australia among Men Who Have Sex with Men","volume":"381","author":"Williamson","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2020.08.002_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrmicro3217","article-title":"Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance","volume":"12","author":"Namraj","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.idc.2020.08.002_bib9","doi-asserted-by":"crossref","first-page":"e01405-18","DOI":"10.1128\/JCM.01405-18","article-title":"Genome-Based Prediction of Bacterial Antibiotic Resistance","volume":"57","author":"Su","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2020.08.002_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/QCO.0000000000000526","article-title":"New antibiotics for community-acquired pneumonia","volume":"32","author":"Kollef","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0140-6736(09)61999-1","article-title":"Community-associated methicillin-resistant Staphylococcus aureus","volume":"375","author":"DeLeo","year":"2010","journal-title":"Lancet"},{"issue":"Suppl 7","key":"10.1016\/j.idc.2020.08.002_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-0691.2009.03097.x","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?","volume":"15","author":"Witte","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2020.08.002_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-97-3-325","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks","volume":"97","author":"Saravolatz","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2020.08.002_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1574-695X.2012.00937.x","article-title":"Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)","volume":"65","author":"Thurlow","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.idc.2020.08.002_bib15","doi-asserted-by":"crossref","first-page":"e00054","DOI":"10.1128\/mBio.00054-15","article-title":"Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing","volume":"6","author":"Alam","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.idc.2020.08.002_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijmm.2011.09.004","article-title":"Livestock-associated methicillin-resistant Staphylococcus aureus in animals and humans","volume":"301","author":"Graveland","year":"2011","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.idc.2020.08.002_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200003093421007","article-title":"Vancomycin-resistant enterococcal infections","volume":"342","author":"Murray","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2020.08.002_bib18","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/AAC.40.11.2605","article-title":"Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States","volume":"40","author":"Coque","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/JCM.36.3.830-832.1998","article-title":"Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci","volume":"36","author":"Silverman","year":"1998","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2020.08.002_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s15010-002-3035-8","article-title":"Antibiotic use and the prevalence of antibiotic resistance in bacteria from healthy volunteers in the Dutch community","volume":"31","author":"Bruinsma","year":"2003","journal-title":"Infection"},{"key":"10.1016\/j.idc.2020.08.002_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0195-6701(97)90179-1","article-title":"Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection","volume":"37","author":"Bates","year":"1997","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.idc.2020.08.002_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/mdr.1999.5.45","article-title":"Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry","volume":"5","author":"Klare","year":"1999","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.idc.2020.08.002_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1067\/mic.2001.117448","article-title":"Community dissemination of vancomycin-resistant Enterococcus faecium","volume":"29","author":"D'Agata","year":"2001","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2020.08.002_bib24","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1128\/AAC.49.10.4382-4385.2005","article-title":"Vancomycin-resistant Enterococcus faecium strains isolated from community wastewater from a semiclosed agri-food system in Texas","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib25","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ajic.2013.05.025","article-title":"Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast Michigan","volume":"41","author":"Omotola","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2020.08.002_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jiph.2014.01.001","article-title":"Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections","volume":"7","author":"Wolfe","year":"2014","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.idc.2020.08.002_bib27","doi-asserted-by":"crossref","first-page":"16964","DOI":"10.1073\/pnas.1006855107","article-title":"Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci","volume":"107","author":"Foucault","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.idc.2020.08.002_bib28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jac\/dkq512","article-title":"Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures","volume":"66","author":"Johnsen","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib29","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1073\/pnas.1500553112","article-title":"Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains","volume":"112","author":"Gilmore","year":"2015","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.idc.2020.08.002_bib30","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJMra070741","article-title":"Acinetobacter infection","volume":"358","author":"Munoz-Price","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2020.08.002_bib31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10096-007-0365-6","article-title":"Community-acquired Acinetobacter infections","volume":"26","author":"Falagas","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib32","doi-asserted-by":"crossref","first-page":"e802","DOI":"10.1016\/j.ijid.2013.03.021","article-title":"Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections","volume":"17","author":"Eveillard","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-0691.2006.01456.x","article-title":"Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology","volume":"12","author":"Poirel","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2020.08.002_bib34","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1086\/652759","article-title":"Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes","volume":"50","author":"Sengstock","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.diagmicrobio.2012.04.002","article-title":"Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010","volume":"73","author":"Queenan","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1086\/502209","article-title":"The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir?","volume":"24","author":"Zeana","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2020.08.002_bib37","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1378\/chest.13-3065","article-title":"A\u00a016-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols","volume":"146","author":"Davis","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.idc.2020.08.002_bib38","doi-asserted-by":"crossref","first-page":"E491","DOI":"10.1111\/1469-0691.12017","article-title":"Acinetobacter baumannii isolates associated with community-acquired pneumonia in West China","volume":"18","author":"Peng","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2020.08.002_bib39","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1086\/504476","article-title":"The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species","volume":"43","author":"Paterson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tim.2008.12.003","article-title":"Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways","volume":"17","author":"Hassett","year":"2009","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.idc.2020.08.002_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4187\/aarc0446","article-title":"Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist","volume":"54","author":"O'Malley","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.idc.2020.08.002_bib42","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1469-0691.2010.03089.x","article-title":"Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals","volume":"16","author":"Rodriguez-Bano","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2020.08.002_bib43","doi-asserted-by":"crossref","first-page":"e91713","DOI":"10.1371\/journal.pone.0091713","article-title":"Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study","volume":"9","author":"Anderson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2020.08.002_bib44","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1128\/AAC.02467-12","article-title":"Bacterial and clinical characteristics of health care- and community-acquired bloodstream infections due to Pseudomonas aeruginosa","volume":"57","author":"Hattemer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1413-8670(10)70046-5","article-title":"Pyogenic liver abscess caused by community-acquired multidrug resistance Pseudomonas aeruginosa","volume":"14","author":"Ulug","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/138161213804070348","article-title":"Enterobacteriaceae that produce extended-spectrum beta-lactamases and AmpC beta-lactamases in the community: the tip of the iceberg?","volume":"19","author":"Pitout","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.idc.2020.08.002_bib47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States","volume":"56","author":"Doi","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib48","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1322678111","article-title":"Global dissemination of a multidrug resistant Escherichia coli clone","volume":"111","author":"Petty","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.idc.2020.08.002_bib49","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/671725","article-title":"Predictors and molecular epidemiology of community-onset extended-spectrum beta-lactamase-producing Escherichia coli infection in a Midwestern community","volume":"34","author":"Banerjee","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2020.08.002_bib50","doi-asserted-by":"crossref","first-page":"e74323","DOI":"10.1371\/journal.pone.0074323","article-title":"Risk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia Coli. an exploratory case-control study","volume":"8","author":"Leistner","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.idc.2020.08.002_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3109\/23744235.2015.1055588","article-title":"Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community, in North West London","volume":"47","author":"Gopal Rao","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.idc.2020.08.002_bib52","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/AAC.02052-13","article-title":"Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries","volume":"58","author":"Rogers","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3201\/eid0802.010025","article-title":"Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns","volume":"8","author":"Ko","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/cid\/cit675","article-title":"Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China","volume":"58","author":"Li","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib55","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.idc.2020.08.002_bib56","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/cid\/ciaa056","article-title":"Unlikely bedfellows: the partnering of antibiotic stewardship programs and the pharmaceutical industry","volume":"71","author":"Tamma","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/QCO.0000000000000623","article-title":"Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia","volume":"33","author":"Paterson","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.idc.2020.08.002_bib58","first-page":"S397","article-title":"Combating antimicrobial resistance: policy recommendations to save lives","volume":"52","author":"Spellberg","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","article-title":"The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria","volume":"9","author":"Nordmann","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib61","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1001\/jama.2008.896","article-title":"Carbapenem-resistant Enterobacteriaceae: a potential threat","volume":"300","author":"Schwaber","year":"2008","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.idc.2020.08.002_bib62","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkq108","article-title":"Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection","volume":"65","author":"Hirsch","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.diagmicrobio.2010.10.013","article-title":"Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections","volume":"69","author":"Neuner","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2012.11.009","article-title":"Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes","volume":"75","author":"van Duin","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib65","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jama.2014.12720","article-title":"New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes","volume":"312","author":"Epstein","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2020.08.002_bib66","first-page":"DC01","article-title":"Emergence of Escherichia coli, Co-Producing NDM-1 and OXA-48 Carbapenemases, in Urinary Isolates, at a Tertiary Care Centre at Central India","volume":"8","author":"Khajuria","year":"2014","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.idc.2020.08.002_bib67","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1086\/675614","article-title":"Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities","volume":"35","author":"Bhargava","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2020.08.002_bib68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1473-3099(11)70059-7","article-title":"Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study","volume":"11","author":"Walsh","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib69","doi-asserted-by":"crossref","first-page":"e37152","DOI":"10.1371\/journal.pone.0037152","article-title":"Identification of New Delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin","volume":"7","author":"Wang","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.idc.2020.08.002_bib70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1473-3099(17)30489-9","article-title":"A\u00a0fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study","volume":"18","author":"Gu","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2020.08.002_bib71","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/jac\/dky164","article-title":"Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan","volume":"73","author":"Huang","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00519-19","article-title":"Identification of a Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae Isolate in the United States","volume":"63","author":"Karlsson","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib73","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/jac\/dkz023","article-title":"Whole genome assembly and functional portrait of hypervirulent extensively drug-resistant NDM-1 and KPC-2 co-producing Klebsiella pneumoniae of capsular serotype K2 and ST86","volume":"74","author":"Liu","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib74","doi-asserted-by":"crossref","DOI":"10.1099\/jmmcr.0.005130","article-title":"A\u00a0case of NDM-carbapenemase-producing hypervirulent Klebsiella pneumoniae sequence type 23 from the UK","volume":"5","author":"Roulston","year":"2018","journal-title":"JMM Case Rep"},{"key":"10.1016\/j.idc.2020.08.002_bib75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jac\/dkz446","article-title":"Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis","volume":"75","author":"Zhang","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s12941-016-0124-6","article-title":"Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China.(Report)","volume":"15","author":"Zheng","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.idc.2020.08.002_bib77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/INF.0000000000000471","article-title":"Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States","volume":"34","author":"Pannaraj","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.idc.2020.08.002_bib78","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1128\/AAC.03320-14","article-title":"Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India","volume":"58","author":"Hussain","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib79","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/AAC.01763-10","article-title":"Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131","volume":"55","author":"Peirano","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2020.08.002_bib80","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkp256","article-title":"The changing epidemiology of resistance","volume":"64","author":"Hawkey","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib81","doi-asserted-by":"crossref","first-page":"e77310","DOI":"10.1371\/journal.pone.0077310","article-title":"A\u00a0treatment plant receiving waste water from multiple bulk drug manufacturers is a reservoir for highly multi-drug resistant integron-bearing bacteria","volume":"8","author":"Marathe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2020.08.002_bib82","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1126\/science.1220761","article-title":"The shared antibiotic resistome of soil bacteria and human pathogens","volume":"337","author":"Forsberg","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.idc.2020.08.002_bib83","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/678057","article-title":"Antimicrobial stewardship programs in inpatient hospital settings: a systematic review","volume":"35","author":"Wagner","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Spec No","key":"10.1016\/j.idc.2020.08.002_bib84","first-page":"44","article-title":"Antibiotic stewardship: a focus on ambulatory care","author":"Gangat","year":"2015","journal-title":"South Dakota Med"},{"key":"10.1016\/j.idc.2020.08.002_bib85","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/665314","article-title":"Impact of isolation on hospital consumer assessment of healthcare providers and systems scores: is isolation isolating?","volume":"33","author":"Vinski","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2020.08.002_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/dkp159","article-title":"Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects","volume":"64","author":"Coates","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2020.08.002_bib87","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s11999-013-2875-0","article-title":"Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections","volume":"471","author":"Chen","year":"2013","journal-title":"Clin Orthop Relat Res"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:18:11Z","timestamp":1760195891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552020300647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0891552020300647"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2020.08.002","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidrug-Resistant Bacteria in the Community","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}